Replimune (REPL) Change in Cash (2017 - 2026)
Replimune (REPL) reported Change in Cash of $86.1 million for Q1 2026, up 240.82% on a YoY basis from $25.3 million in Q1 2025, and up 316.77% sequentially from $20.7 million in Q4 2025.
Replimune (REPL) Change in Cash (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Change in Cash data on file, last reported at $86.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 240.82% year-over-year to $86.1 million; the trailing twelve-month figure through Mar 2026 stood at $97.9 million (up 167.03% YoY), and the FY2026 full-year result was $97.9 million, up 167.03% from the prior year.
- Change in Cash improved to $86.1 million in Q1 2026, from $20.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $117.7 million in Q4 2022 to a low of -$61.1 million in Q1 2025.
- A 5-year average of $4.5 million and a median of -$13.7 million in 2025 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 525.14% in 2022 and tumbled 736.95% in 2023, its largest moves.
- Tracing REPL's Change in Cash over 5 years: stood at $117.7 million in 2022, then tumbled by 81.59% to $21.7 million in 2023, then jumped by 171.02% to $58.7 million in 2024, then slumped by 64.85% to $20.7 million in 2025, then jumped by 316.77% to $86.1 million in 2026.
- Business Quant data shows REPL's Change in Cash at $86.1 million in Q1 2026, $20.7 million in Q4 2025, and $4.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 86.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.07 Mn |
| Dec 31, 2025 | 20.65 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | -13.74 Mn |
| Mar 31, 2025 | -61.12 Mn |
| Dec 31, 2024 | 58.75 Mn |
| Sep 30, 2024 | -38.16 Mn |
| Jun 30, 2024 | 77.20 Mn |
| Mar 31, 2024 | -23.15 Mn |
| Dec 31, 2023 | 21.68 Mn |
| Sep 30, 2023 | -30.49 Mn |
| Jun 30, 2023 | -40.11 Mn |
| Mar 31, 2023 | -60.08 Mn |
| Dec 31, 2022 | 117.74 Mn |
| Sep 30, 2022 | -23.32 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | -26.33 Mn |
| Dec 31, 2021 | -27.69 Mn |
| Sep 30, 2021 | -32.56 Mn |
| Jun 30, 2021 | 10.01 Mn |